| The proceedings of the 17th International Conference on Chelation: application of effective chelation therapies in iron loading and non iron loading conditions, and the gap in the prevention and treatment policies on thalassemia between developed and developing countries. | |
| | |
MedLine Citation:
|
PMID: 19814673 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Substantial progress in the use of chelating drugs for the treatment of iron overload and of non iron loading conditions has been presented during the 17th International Conference on Chelation (ICOC) held in November 2007 at Shenzhen, China. Major challenges lie ahead for the prevention and treatment of thalassemia in China, India, Thailand, Indonesia and many other developing countries where millions of heterozygote thalassemia carriers live and thousands of homozygote thalassemia patients are born annually. The progressive improvement of the economic climate in developing countries will increase the demand and resources for more prenatal and antenatal diagnoses, transfusions and chelation therapy in forthcoming years. Despite the major advances in diagnosis and treatment in developed countries, the vast majority of thalassemia patients in developing countries die untreated because they cannot afford the cost of transfusions and chelation therapy. New approaches and infrastructures and more efforts are needed to overcome the difficulties of supplying new techniques and treatments to patients in developing countries. International and local organizations need to be persuaded to act collectively and effectively to improve chelation and related treatments for thalassemia and other conditions, especially at this time that universally effective and inexpensive chelation therapies can be applied. |
| | |
Authors:
|
George J Kontoghiorghes |
Related Documents
:
|
10465173 - Effect of idebenone on cardiomyopathy in friedreich's ataxia: a preliminary study. 9202563 - Anaemia associated with androgen deprivation in patients with prostate cancer receiving... 22244293 - Thallium-201 for cardiac stress tests: residual radioactivity worries patients and secu... |
Publication Detail:
|
Type: Introductory Journal Article |
Journal Detail:
|
Title: Hemoglobin Volume: 33 ISSN: 1532-432X ISO Abbreviation: Hemoglobin Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-10-09 Completed Date: 2010-01-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7705865 Medline TA: Hemoglobin Country: England |
Other Details:
|
Languages: eng Pagination: 283-6 Citation Subset: IM |
Affiliation:
|
Postgraduate Research Institute of Science, Technology, Environment and Medicine, Limassol, Cyprus. kontoghiorghes.g.j@pri.ac.cy |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Chelation Therapy
/
economics* Clinical Trials as Topic Developing Countries / economics Humans Iron / metabolism Iron Chelating Agents / therapeutic use* Iron Overload / drug therapy* Thalassemia / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Iron Chelating Agents; 7439-89-6/Iron |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chronic total occlusions in peripheral vasculature: techniques and devices.
Next Document: Advances in the prevention and treatment are changing thalassemia from a fatal to a chronic disease....